OAM
HOLX

Oppenheimer Asset Management’s Hologic HOLX Stock Holding History

Oppenheimer Asset Management’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,857
Closed -$1.21M – 1149
2025
Q3 		$1.21M Buy
17,857
+3,069
+21% +$204K 0.01% 706
2025
Q2 		$964K Buy
14,788
+246
+2% +$14.7K 0.01% 760
2025
Q1 		$898K Sell
14,542
-226
-2% -$15K 0.01% 739
2024
Q4 		$1.06M Sell
14,768
-19,840
-57% -$1.55M 0.01% 702
2024
Q3 		$2.82M Sell
34,608
-3,815
-10% -$305K 0.03% 454
2024
Q2 		$2.85M Buy
38,423
+3,876
+11% +$291K 0.04% 433
2024
Q1 		$2.69M Buy
34,547
+4,490
+15% +$334K 0.04% 411
2023
Q4 		$2.15M Sell
30,057
-4,890
-14% -$340K 0.03% 494
2023
Q3 		$2.43M Buy
34,947
+2,375
+7% +$179K 0.04% 429
2023
Q2 		$2.64M Buy
32,572
+19,646
+152% +$1.61M 0.04% 435
2023
Q1 		$1.04M Sell
12,926
-105
-0.8% -$8.45K 0.02% 677
2022
Q4 		$975K Sell
13,031
-170
-1% -$12.1K 0.02% 690
2022
Q3 		$852K Buy
13,201
+478
+4% +$33.1K 0.02% 702
2022
Q2 		$882K Sell
12,723
-68
-0.5% -$5.05K 0.01% 711
2022
Q1 		$983K Buy
12,791
+9,680
+311% +$696K 0.01% 745
2021
Q4 		$238K Sell
3,111
-95
-3% -$6.98K ﹤0.01% 1135
2021
Q3 		$236K Sell
3,206
-36
-1% -$2.7K ﹤0.01% 1104
2021
Q2 		$217K Sell
3,242
-70
-2% -$4.68K ﹤0.01% 1133
2021
Q1 		$246K Sell
3,312
-122
-4% -$9.26K ﹤0.01% 1066
2020
Q4 		$251K Buy
+3,434
New +$242K ﹤0.01% 1025
2017
Q4 		– Sell
-3,038
Closed -$112K – 1243
2017
Q3 		$112K Sell
3,038
-12,149
-80% -$490K ﹤0.01% 1176
2017
Q2 		$690K Buy
15,187
+638
+4% +$28.2K 0.02% 694
2017
Q1 		$619K Buy
+14,549
New +$593K 0.02% 725

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Oppenheimer Asset Management's HOLX Position: Q4 2025 in Review

Oppenheimer Asset Management sold out of Hologic (HOLX) in Q4 2025, closing a stake of 17,857 shares — an estimated $1.21M sold.

Oppenheimer Asset Management first reported a position in HOLX in Q1 2017 and held it in 23 quarters. The position peaked at $2.85M in Q2 2024. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

  • Oppenheimer Asset Management reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
  • Oppenheimer Asset Management sold 17,857 Hologic shares in Q4 2025, an estimated $1.21M.
  • Oppenheimer Asset Management first reported a position in Hologic in Q1 2017 and held it in 23 quarters.
  • Oppenheimer Asset Management's Hologic position peaked at $2.85M in Q2 2024.
  • 749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Oppenheimer Asset Management's 13F filing for Q4 2025, filed 2 Feb 2026.